Published in World J Gastroenterol on June 07, 2005
Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study. Gastric Cancer (2014) 1.02
Quality of life of long-term survivors after a distal subtotal gastrectomy. Cancer Res Treat (2010) 1.01
Changes of quality of life after gastric cancer surgery. J Gastric Cancer (2012) 0.96
Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF). BMC Cancer (2006) 0.94
Quality of life: A critical outcome for all surgical treatments of gastric cancer. World J Gastroenterol (2016) 0.85
Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments. Gastric Cancer (2006) 0.85
Effect of rikkunshito, a Japanese herbal medicine, on gastrointestinal symptoms and ghrelin levels in gastric cancer patients after gastrectomy. Gastric Cancer (2012) 0.85
Single-tube-genotyping of gastric cancer related SNPs by directly using whole blood and paper-dried blood as starting material. World J Gastroenterol (2006) 0.82
The quality of life after a total gastrectomy with extended lymphadenectomy and omega type oesophagojejunostomy for gastric adenocarcinoma without distant metastases. BMC Surg (2012) 0.81
A comparison of endoscopic submucosal dissection (ESD) and radical surgery for early gastric cancer: a retrospective study. World J Surg Oncol (2015) 0.80
Quality of life in patients with gastric cancer: translation and psychometric evaluation of the Iranian version of EORTC QLQ-STO22. BMC Cancer (2009) 0.80
Systematic review on quality of life outcomes after gastrectomy for gastric carcinoma. J Gastrointest Oncol (2015) 0.78
Factors related to clinically relevant fatigue in disease-free stomach cancer survivors and expectation-outcome consistency. Support Care Cancer (2014) 0.78
Postoperative quality of life and dysfunction in patients after combined total gastrectomy and esophagectomy. Ann Med Surg (Lond) (2017) 0.75
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst (2000) 133.74
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol (1993) 18.75
Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA (2002) 5.30
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol (1997) 4.69
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol (1996) 4.07
Gastric cancer. Lancet (2003) 3.96
Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology (2003) 3.77
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol (2000) 2.95
Quality of life after laparoscopy-assisted Billroth I gastrectomy. Ann Surg (1999) 1.93
Routine administration of Health Related Quality of Life (HRQoL) and needs assessment instruments to improve psychological outcome--a systematic review. Psychol Med (2002) 1.90
Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns (2003) 1.85
Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg (1992) 1.76
Quality of life following radical surgical treatment of gastric carcinoma. World J Surg (1999) 1.61
Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer (2001) 1.58
Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol (2002) 1.52
Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol (2003) 1.48
The significance of quality of life in health care. Qual Life Res (2003) 1.47
Clinical outcome of proximal versus total gastrectomy for proximal gastric cancer. World J Surg (2002) 1.41
Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life. World J Surg (1998) 1.27
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol (2001) 1.24
The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials. Eur J Cancer (2003) 1.15
Validation of the EORTC QLQ-SAT32 cancer inpatient satisfaction questionnaire by self- versus interview-assessment comparison. Patient Educ Couns (2004) 1.14
Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures. World J Surg (1997) 1.13
Pouch versus esophagojejunostomy after total gastrectomy: a randomized clinical trial. World J Surg (1987) 1.11
Long term consequences of gastrectomy for patient's quality of life: the impact of reconstructive techniques. Am J Gastroenterol (1999) 1.10
Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg (2003) 1.10
Quality of life in venous disease. Thromb Haemost (2003) 1.08
Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology (1999) 1.07
Development of quality of life questionnaire in Japan: quality of life assessment of cancer patients receiving chemotherapy. Psychooncology (1999) 1.06
Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol (1990) 1.05
Impact of surgical procedure for gastric cancer on quality of life. Br J Surg (2003) 1.05
Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection. Hepatogastroenterology (1997) 1.05
Development of a questionnaire to evaluate the information needs of cancer patients: the EORTC questionnaire. Patient Educ Couns (2004) 1.04
Prospective randomized trial of combined oncological therapy for gastric carcinoma. Cancer (1979) 1.01
Quality of life in patients undergoing systemic therapy for advanced breast cancer. Lancet Oncol (2002) 1.01
Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival. Cancer (1996) 0.98
Nutritional and life-quality consequences of aboral pouch construction after total gastrectomy: a randomized, controlled study. Eur J Surg Oncol (2001) 0.96
Quality of life after gastrectomy: Longmire's reconstruction alone compared with additional pouch reconstruction. World J Surg (2002) 0.93
Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer. Acta Oncol (1998) 0.90
Health-related quality of life varies with personality types: a comparison among cancer patients, non-cancer patients and healthy individuals in a Japanese population. Qual Life Res (1998) 0.90
The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy. Anticancer Res (2003) 0.89
A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterology (1999) 0.87
A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: a new concept of clinical benefit response for non-measurable type of gastric cancer. Jpn J Clin Oncol (2003) 0.86
Reconstruction of the food passage after total gastrectomy: randomized trial. World J Surg (1995) 0.86
The cognitive-spiritual dimension--an important addition to the assessment of quality of life: validation of a questionnaire (SELT-M) in patients with advanced cancer. Ann Oncol (1998) 0.85
Symptomatic outcome following resection of gastric cancer. Surg Oncol (1995) 0.85
Quality of life after surgical treatment of gastric carcinoma. Eur J Surg (1998) 0.82
Symptom control may improve food intake, body composition, and aspects of quality of life after gastrectomy in cancer patients. Dig Dis Sci (2001) 0.82
Total versus subtotal gastrectomy in cancer of the distal stomach: facts and fantasy. Eur J Surg Oncol (1992) 0.80
Long-term effects of jejunal pouch added to Roux-en-Y reconstruction after total gastrectomy. Gastric Cancer (2001) 0.80
Long-term quality of life in patients after total gastrectomy. Cancer Nurs (1999) 0.78
Docetaxel plus 5-fluorouracil for terminal gastric cancer patients with peritoneal dissemination. Hepatogastroenterology (2003) 0.77
[Interim report of JFMTC study no. 20 on the effectiveness of high dose CDDP plus 5-FU regimen as an adjuvant therapy for far-advanced cancer of the stomach]. Gan To Kagaku Ryoho (2000) 0.77
Assessing quality of life in chronic non-specific lung disease--a review of empirical studies published between 1980 and 1994. Qual Life Res (1996) 0.77
[Interim report on JFMTC Study no. 21 on the effectiveness of UFT as an adjuvant therapy for semi-advanced cancer of the stomach]. Gan To Kagaku Ryoho (2000) 0.77
[Interim report of JFMC study no. 23--phase III randomized clinical trial on the effectiveness of low-dose cisplatin plus 5-FU as a postoperative adjuvant chemotherapy for advanced gastric cancer]. Gan To Kagaku Ryoho (2002) 0.76
Quality of life in gastric cancer prior to gastrectomy. Qual Life Res (1996) 0.76
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med (2010) 27.12
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol (2009) 21.94
Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA (2010) 5.04
First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. J Clin Oncol (2009) 4.05
Simple and accurate electrocardiographic criteria to differentiate takotsubo cardiomyopathy from anterior acute myocardial infarction. J Am Coll Cardiol (2010) 2.83
Virtual bronchoscopic navigation combined with ultrathin bronchoscopy. A randomized clinical trial. Am J Respir Crit Care Med (2013) 2.78
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). Lancet Oncol (2010) 2.73
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol (2013) 2.45
Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional study. Respir Care (2012) 2.00
Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis. J Natl Cancer Inst (2013) 1.90
Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol (2013) 1.79
Frequency of and variables associated with the EGFR mutation and its subtypes. Int J Cancer (2010) 1.79
High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival. Breast Cancer Res Treat (2013) 1.78
Increased graft occlusion or string sign in composite arterial grafting for mildly stenosed target vessels. Ann Thorac Surg (2010) 1.75
Bidi smoking and oral cancer: a meta-analysis. Int J Cancer (2003) 1.74
Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial. Ann Surg Oncol (2013) 1.66
Differences in negative T waves between takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction. Circ J (2011) 1.59
Conditional versus unconditional logistic regression in the medical literature. J Clin Epidemiol (2003) 1.57
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial. J Hypertens (2014) 1.56
Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection. Eur J Cardiothorac Surg (2013) 1.56
Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4. J Biol Chem (2006) 1.54
Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Gastric Cancer (2012) 1.54
Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas (2011) 1.52
Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study. J Clin Oncol (2010) 1.51
Long-term quality of life of donors after living donor liver transplantation. Liver Transpl (2012) 1.47
Inner segment/outer segment junction assessed by spectral-domain optical coherence tomography in patients with idiopathic epiretinal membrane. Am J Ophthalmol (2010) 1.47
Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design. Pharm Stat (2006) 1.44
Laparoscopic surgery for gastric cancer: a collective review with meta-analysis of randomized trials. J Am Coll Surg (2010) 1.42
Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry. Circ J (2015) 1.41
Augmentation index is elevated in aortic aneurysm and dissection. Ann Thorac Surg (2009) 1.40
Factors affecting low birth weight at four central hospitals in vientiane, Lao PDR. Nagoya J Med Sci (2010) 1.37
Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): study design and rationale. Catheter Cardiovasc Interv (2013) 1.37
Exploring and validating surrogate endpoints in colorectal cancer. Lifetime Data Anal (2008) 1.34
Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis. J Natl Cancer Inst (2013) 1.28
The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer (2003) 1.27
Application of the transorally inserted anvil (OrVil) after laparoscopy-assisted total gastrectomy. Surg Endosc (2010) 1.26
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer (2013) 1.24
Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. Am J Kidney Dis (2009) 1.23
Knowledge, attitudes and practices regarding HIV/AIDS among male high school students in Lao People's Democratic Republic. J Int AIDS Soc (2013) 1.23
Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc (2013) 1.22
A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study). Anticancer Res (2007) 1.18
Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc (2013) 1.18
Factors affecting the utilization of antenatal care services among women in Kham District, Xiengkhouang province, Lao PDR. Nagoya J Med Sci (2010) 1.17
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme. J Neurosurg (2008) 1.16
Japan's share of articles in orthopedics. J Orthop Sci (2002) 1.13
A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Cancer (2010) 1.13
Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg (2012) 1.13
Preoperative inner segment/outer segment junction in spectral-domain optical coherence tomography as a prognostic factor in epiretinal membrane surgery. Retina (2011) 1.10
Healthcare workers' knowledge and practices regarding expanded program on immunization in Kalasin, Thailand. Nagoya J Med Sci (2011) 1.09
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother (2006) 1.09
Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: a comparative study comparing three surgical procedures. Ann Surg Oncol (2011) 1.08
Statistical comparison of random allocation methods in cancer clinical trials. Control Clin Trials (2004) 1.07
Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: clinical benefit with optimal patient selection. Lung Cancer (2011) 1.07
Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol (2004) 1.07
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy. Cancer Chemother Pharmacol (2013) 1.03
Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis. Anesth Analg (2013) 1.03
Extensive reconstruction of the left anterior descending coronary artery with an internal thoracic artery graft. Ann Thorac Surg (2011) 1.02
Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis. Radiology (2014) 1.02
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02. Support Care Cancer (2009) 1.02
Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas (2009) 1.01
New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis. Auris Nasus Larynx (2011) 1.01
Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer. Cancer Chemother Pharmacol (2013) 1.01
Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial. BMC Cancer (2012) 1.01
Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment. Respirology (2008) 1.00
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial. Support Care Cancer (2012) 1.00
Individual patient based meta-analysis of lentinan for unresectable/recurrent gastric cancer. Anticancer Res (2009) 1.00
Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms. Jpn J Clin Oncol (2011) 1.00
Prevalence of cigarette and bidi smoking among rickshaw pullers in Dhaka city. Prev Med (2006) 1.00
Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer. Laryngoscope (2014) 1.00
Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: a placebo-controlled double-blind randomized phase II study (the GONE Study). Jpn J Clin Oncol (2009) 0.99
Antibiotic use in Vietnamese hospitals: a multicenter point-prevalence study. Am J Infect Control (2012) 0.99
Knowledge, attitude and practice regarding dengue among people in Pakse, Laos. Nagoya J Med Sci (2009) 0.99
Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP. J Biol Chem (2008) 0.99
¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry. Ann Nucl Med (2010) 0.99
Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection. Gastrointest Endosc (2011) 0.99
Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer. Gastric Cancer (2004) 0.99
Pattern of lymph node metastasis spread in pancreatic cancer. Pancreas (2011) 0.99
Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: quality of life analysis of North East Japan Study Group 002 Trial. Oncologist (2012) 0.98
Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11. Anticancer Res (2010) 0.98
A meta-analysis of (18)F-Fluoride positron emission tomography for assessment of metastatic bone tumor. Ann Nucl Med (2010) 0.98
A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data. Jpn J Clin Oncol (2006) 0.98
An early and simple predictor of severe left main and/or three-vessel disease in patients with non-ST-segment elevation acute coronary syndrome. Am J Cardiol (2010) 0.97
Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. Cancer Sci (2011) 0.96
Nutritional recovery after open and laparoscopic gastrectomies. Gastric Cancer (2011) 0.96
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials. Cancer Immunol Immunother (2005) 0.96
Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis. PLoS One (2011) 0.96
Injury and pre-hospital trauma care in Hanoi, Vietnam. Injury (2008) 0.96